Brain, Vol 121, Issue 6 1155-1164, Copyright © 1998 by Oxford University Press
S McDowell, J Whyte and M D'Esposito
We examined the effects of low-dose bromocriptine, a D2 dopamine receptor
agonist, on processes thought to be subserved by the prefrontal cortex,
including working memory and executive function, in individuals with
traumatic brain injury. A group of 24 subjects was tested using a
double-blind, placebo-controlled crossover trial, counterbalanced for
order. Bromocriptine was found to improve performance on some tasks thought
to be subserved by prefrontal function, but not others. Specifically, there
was improvement in performance on clinical measures of executive function
and in dual-task performance, but not measures that tap the ability to
maintain information in working memory without significant executive
demands. Also, on control tasks not thought to be dependent on the
prefrontal cortex, no improvement on bromocriptine was noted. These results
demonstrate a selective effect of bromocriptine on cognitive processes
which involve executive control, and provide a foundation for potential
therapies for patients with prefrontal damage causing dysexecutive
syndromes.
ARTICLES
Differential effect of a dopaminergic agonist on prefrontal function in traumatic brain injury patients
Moss Rehabilitation Research Institute, Temple University School of Medicine, Philadelphia, PA, USA.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. Vaishnavi, V. Rao, and J. R. Fann Neuropsychiatric Problems After Traumatic Brain Injury: Unraveling the Silent Epidemic Psychosomatics, May 1, 2009; 50(3): 198 - 205. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Takahashi, M. Kato, H. Takano, R. Arakawa, M. Okumura, T. Otsuka, F. Kodaka, M. Hayashi, Y. Okubo, H. Ito, et al. Differential Contributions of Prefrontal and Hippocampal Dopamine D1 and D2 Receptors in Human Cognitive Functions J. Neurosci., November 12, 2008; 28(46): 12032 - 12038. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. Huey, K. T. Putnam, and J. Grafman A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia Neurology, January 10, 2006; 66(1): 17 - 22. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Lipsky, M. B. Sparling, L. M. Ryan, K. Xu, A. M. Salazar, D. Goldman, and D. L. Warden Association of COMT Val158Met Genotype With Executive Functioning Following Traumatic Brain Injury J Neuropsychiatry Clin Neurosci, November 1, 2005; 17(4): 465 - 471. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Mehta, E. C. Hinton, A. J. Montgomery, R. A. Bantick, and P. M. Grasby Sulpiride and mnemonic function: effects of a dopamine D2 receptor antagonist on working memory, emotional memory and long-term memory in healthy volunteers J Psychopharmacol, January 1, 2005; 19(1): 29 - 38. [Abstract] [PDF] |
||||
![]() |
S. C.J. Huijbregts, N. F. Kalkers, L. M.J. de Sonneville, V. de Groot, I. E.W. Reuling, and C. H. Polman Differences in cognitive impairment of relapsing remitting, secondary, and primary progressive MS Neurology, July 27, 2004; 63(2): 335 - 339. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Budson, K. J. Michalska, D. M. Rentz, C. C. Joubert, K. R. Daffner, D. L. Schacter, and R. A. Sperling Use of a false recognition paradigm in an Alzheimer's disease clinical trial: A pilot study American Journal of Alzheimer's Disease and Other Dementias, March 1, 2002; 17(2): 93 - 100. [Abstract] [PDF] |
||||
![]() |
I. Litvan Therapy and management of frontal lobe dementia patients Neurology, June 12, 2001; 56(90004): S41 - 45. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Robinson Rehabilitation applications in caring for patients with Pick's disease and frontotemporal dementias Neurology, June 12, 2001; 56(90004): S56 - 58. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. J. Schmitt, M. J. Kruizinga, and W. J. Riedel Non-serotonergic pharmacological profiles and associated cognitive effects of serotonin reuptake inhibitors J Psychopharmacol, May 1, 2001; 15(3): 173 - 179. [Abstract] [PDF] |
||||
![]() |
M. P. Alexander Chronic Akinetic Mutism After Mesencephalic-Diencephalic Infarction: Remediated with Dopaminergic Medications Neurorehabil Neural Repair, March 1, 2001; 15(2): 151 - 156. [Abstract] [PDF] |
||||
![]() |
M. A. Mehta, A. M. Owen, B. J. Sahakian, N. Mavaddat, J. D. Pickard, and T. W. Robbins Methylphenidate Enhances Working Memory by Modulating Discrete Frontal and Parietal Lobe Regions in the Human Brain J. Neurosci., March 15, 2000; 20(6): RC65 - RC65. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Granon, F. Passetti, K. L. Thomas, J. W. Dalley, B. J. Everitt, and T. W. Robbins Enhanced and Impaired Attentional Performance After Infusion of D1 Dopaminergic Receptor Agents into Rat Prefrontal Cortex J. Neurosci., February 1, 2000; 20(3): 1208 - 1215. [Abstract] [Full Text] [PDF] |
||||






